Lumen Bioscience

Seattle-based Lumen Bioscience, Inc. has developed a new spirulina-based drug discovery, manufacturing, and delivery platform for highly prevalent diseases and disorders that have been difficult to address with conventional biopharmaceutical tools. Lumen's unique platform offers the potential to transform the biologics industry through increased sp... eed, straightforward assembly of cocktail therapeutics, mass-market scale, and exponentially lower costs than legacy approaches. Lumen is advancing investigational oral biologic drugs and dietary supplements designed to act locally in the gut, with a pipeline targeting weight loss, C. difficile infection, inflammatory bowel disease, kidney stone disease, traveler's diarrhea, and other high prevalence conditions.Read More